Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 1140, Suchdauer: 1.03s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Neutrophils as critical orchestrators of chronic inflammation

von Torfs, Kaat ; Vermeersch, Gaël ; Gouwy, Mieke ; et al.

Cellular & Molecular Immunology. 23(2):123-149
- Zum Volltext (via ReDI)
Merkliste

2
Spleen Volume Reduction and Transfusion Independence With Momelotinib Versus Ruxolitinib and Associated Overall Survival With Momelotinib in JAK Inhibitor–Naive Patients With Myelofibrosis and Anemia: Subgroup Analyses of SIMPLIFY-1

von Palandri, Francesca ; Schaap, Nicolaas P.M. ; Rey, Jerome ; et al.

In Clinical Lymphoma, Myeloma and Leukemia May 2026 26(5):297-308
- View full text via DOI
Merkliste

3
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib – final 6-year results from a Belgian registry

von Timothy Devos ; Dries Deeren ; Koen Theunissen ; et al.

Hematology, Vol 30, Iss 1 (2025)

Schlagworte: Ponatinib; real-world evidence; registry; Philadelphia chromosome-positive acute lymphoblastic leukemia; chronic myeloid leukemia; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

4
Genomic profiling for decision-making in post–polycythemia vera and post–essential thrombocythemia myelofibrosis

von Mora, Barbara ; Palandri, Francesca ; Guglielmelli, Paola ; et al.

In Blood February 2026
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

5
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera

von Beauverd, Yan ; Ianotto, Jean-Christophe ; Thaw, Kyaw Htin ; et al.

Leukemia. 39(5):1135-1145
- Zum Volltext (via ReDI)
Merkliste

6
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

von Steffen Koschmieder ; Clemens Schulte ; Eyck von der Heyde ; et al.

Therapeutic Advances in Hematology, Vol 16 (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

7
Neutrophils in BCR::ABL1 negative MPN: Contributors or bystanders of fibrosis?

von Vermeersch, Gaël ; Gouwy, Mieke ; Proost, Paul ; et al.

In Blood Reviews
- View full text via DOI
Merkliste

8
Platelet transfusion guidelines for thrombocytopenic patients in non-surgical and non-traumatic care settings: A systematic review and methodological quality assessment

von Criel, Yana ; Feys, Hendrik B. ; De Buck, Emmy ; et al.

In Blood Reviews
- View full text via DOI
Merkliste

9
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria

von Schrezenmeier, Hubert ; Kulasekararaj, Austin ; Mitchell, Lindsay ; et al.

Annals of Hematology. 103(1):5-15
- Zum Volltext (via ReDI)
Merkliste

10
Germline heterozygous SH2B3‐mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation

von Gaël Vermeersch ; Timothy Devos ; Helena Devos ; et al.

eJHaem, Vol 4, Iss 4, Pp 1143-1147 (2023)

Schlagworte: erythrocytosis; idiopathic erythrocytosis; myeloid function and development; myeloproliferative disorder; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

11
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

von Stephen T. Oh ; Srdan Verstovsek ; Vikas Gupta ; et al.

eJHaem, Vol 5, Iss 1, Pp 105-116 (2024)

Schlagworte: bone marrow fibrosis; JAK inhibitor; momelotinib; myelofibrosis; ruxolitinib; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

12
Exploring the relationship between anellovirus load and clinical variables in hospitalized COVID-19 patients: Implications for immune activation and inflammation

von Thijssen, Marijn ; Devos, Timothy ; Meyfroidt, Geert ; et al.

In IJID Regions December 2023 9:49-54
- View full text via DOI
Merkliste

13
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

von Koschmieder, Steffen ; Schulte, Clemens ; Baum, Volker ; et al.

Therapeutic advances in hematology 16, 1-14 (2025). doi:10.1177/20406207251342199

Schlagworte: info:eu-repo/classification/ddc/610
- View full text via BASE
Merkliste

14
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry

von Höchsmann, Britta ; Peffault de Latour, Regis ; Hill, Anita ; et al.

Annals of Hematology. 102(11):2979-2988
- Zum Volltext (via ReDI)
Merkliste

15
Incidence of blast phase in myelofibrosis according to anemia severity

von Barbara Mora ; Margherita Maffioli ; Elisa Rumi ; et al.

eJHaem, Vol 4, Iss 3, Pp 679-689 (2023)

Schlagworte: acute myeloid leukemia; essential thrombocythemia; myelofibrosis; polycythemia vera; ruxolitinib; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

16
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative

von Richard K. Wyse ; Tom Isaacs ; Roger A. Barker ; et al.

Journal of Parkinson’s Disease, Vol 14 (2024)

Schlagworte: Medicine
- View full text via DOI
Merkliste

17
Prognostic models for prediction of perioperative allogeneic red blood cell transfusion in adult cardiac surgery: A systematic review and meta-analysis

von Van den Eynde, Raf ; Vrancken, Annemarie ; Foubert, Ruben ; et al.

ISSN:0041-1132 ; ISSN:1537-2995 ; Transfusion, vol. 65 (2), (397-409.

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Hematology; anesthesia; cardiac surgical procedures; prognosis; risk assessment; transfusion; ARTERY-BYPASS-SURGERY; GRAFT-SURGERY; RISK; TOOL; APPLICABILITY; CONSERVATION; VALIDATION; STRATEGIES; PROBAST; BIAS; Humans; Erythrocyte Transfusion; Perioperative Care; Adult; GUIDELINES; MANAGEMENT; 1102 Cardiorespiratory Medicine and Haematology; 1103 Clinical Sciences; 1107 Immunology; Cardiovascular System & Hematology; 3201 Cardiovascular medicine and haematology; 3202 Clinical sciences
- View full text via BASE
Merkliste

18
Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study

von Engelen, Matthias M. ; Van Thillo, Quentin ; Betrains, Albrecht ; et al.

In Research and Practice in Thrombosis and Haemostasis October 2022 6(7)
- View full text via DOI
Merkliste

19
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

von Sobas, Marta ; Kiladjian, Jean-Jacques ; Beauverd, Yan ; et al.

In Blood Advances 13 September 2022 6(17):5171-5183
- View full text via DOI
Merkliste

20
Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study

von Passamonti, Francesco ; Palandri, Francesca ; Saydam, Guray ; et al.

In The Lancet Haematology July 2022 9(7):e480-e492
- View full text via DOI
Merkliste

21
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis

von Gael Vermeersch ; Paul Proost ; Sofie Struyf ; et al.

Haematologica, Vol 999, Iss 1 (2024)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

22
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

von Dan Xia ; Steve Lianoglou ; Thomas Sandmann ; et al.

Molecular Neurodegeneration, Vol 17, Iss 1, Pp 1-29 (2022)

Schlagworte: Neuritic plaques; Vascular amyloid; Neurodegeneration; Astrogliosis; Phagocytic microglia; Lipid dyshomeostasis; Neurology. Diseases of the nervous system; RC346-429; Geriatrics; RC952-954.6
- View full text via DOI
Merkliste

23
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients

von Mora, Barbara ; Guglielmelli, Paola ; Kuykendall, Andrew ; et al.

Leukemia. 36(10):2453-2460
- Zum Volltext (via ReDI)
Merkliste

24
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis

von Mesa, Ruben ; Harrison, Claire ; Oh, Stephen T. ; et al.

Leukemia. 36(9):2261-2268
- Zum Volltext (via ReDI)
Merkliste

25
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

von Mesa, Ruben ; Verstovsek, Srdan ; Platzbecker, Uwe ; et al.

Schlagworte: Settore MEDS-09/B - Malattie del sangue
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag